Neovasc (NVCN) PT Lowered to $2 at Leerink Partners; 'Tiara Clinical Trials Continue to Progress'

Go back to Neovasc (NVCN) PT Lowered to $2 at Leerink Partners; 'Tiara Clinical Trials Continue to Progress'
(NASDAQ: NVCN) Delayed: 0.78 +0.04 (5.41%)
Previous Close $0.74    52 Week High $5.04 
Open $0.78    52 Week Low $0.37 
Day High $0.80    P/E N/A 
Day Low $0.74    EPS $0.00 
Volume 797,739